This event will present the most updated and original content on communicating the cost and budget effectiveness of high-value drugs to key stakeholders in a high potential and exciting emerging region.
Hear which reforms are taking place now in key CEE countries.
Learn which innovative reimbursement schemes can be implemented in CEE.
Understand the drivers for risk-sharing and innovative pricing schemes in the region.
Learn how HTAs are evolving in CEE, their priorities and methodologies.
Find out how health budgets are being affected in the global economic crisis.
Understand how payers are evaluating various reimbursement models and what they define as “value”.
Benchmark, network and co-operate with policy makers, key opinion leaders, payers, pharma companies, academia and patient groups.